These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18852066)

  • 81. Exelixis: integrated drug-discovery and development platform for human therapeutics.
    McCarthy AA
    Chem Biol; 2005 Apr; 12(4):407-8. PubMed ID: 15850973
    [No Abstract]   [Full Text] [Related]  

  • 82. Drug discovery: in the eye of the beholder.
    Pearson H
    Nature; 2003 Aug; 424(6952):990-1. PubMed ID: 12944936
    [No Abstract]   [Full Text] [Related]  

  • 83. [The future of pharmacogenetics--cost-effectiveness and barriers].
    Gyrd-Hansen D
    Ugeskr Laeger; 2005 May; 167(20):2153-5. PubMed ID: 15987071
    [No Abstract]   [Full Text] [Related]  

  • 84. [News in pharmaceutics].
    Arch Pediatr; 2013 Dec; 20(12):1380-4. PubMed ID: 24404599
    [No Abstract]   [Full Text] [Related]  

  • 85. Profiles of four top biotech companies in India.
    Suresh N; Rao ChS
    Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
    [No Abstract]   [Full Text] [Related]  

  • 86. Pharmacogenetics: development issues and solutions for safe and effective medicines.
    Arnold HP; McHale D
    Pharmacogenomics; 2006 Mar; 7(2):149-55. PubMed ID: 16515393
    [No Abstract]   [Full Text] [Related]  

  • 87. Biotech acquisitions by big pharma: why and what is next.
    Malik NN
    Drug Discov Today; 2009 Sep; 14(17-18):818-21. PubMed ID: 19584004
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Proceedings of the plenary sessions of the 19th International Congress of Chemotherapy. Montreal, Canada, July 16-21, 1995.
    Am J Med; 1995 Dec; 99(6A):1S-92S. PubMed ID: 8585527
    [No Abstract]   [Full Text] [Related]  

  • 89. Pharmaceutical companies and medical therapeutics education.
    Somberg JC
    Am J Ther; 2006; 13(2):93. PubMed ID: 16645422
    [No Abstract]   [Full Text] [Related]  

  • 90. Quality-by-design for biotechnology-related pharmaceuticals.
    Mandenius CF; Graumann K; Schultz TW; Premstaller A; Olsson IM; Petiot E; Clemens C; Welin M
    Biotechnol J; 2009 May; 4(5):600-9. PubMed ID: 19418475
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Does the European pharmaceutical industry have a future?
    McKillop T
    Circulation; 2006 Feb; 113(5):f19-20. PubMed ID: 16468149
    [No Abstract]   [Full Text] [Related]  

  • 92. Role of the laboratory in leveraging adoption of pharmacogenetics.
    Barash CI
    Am Clin Lab; 2001 Sep; 20(8):35-7. PubMed ID: 11586941
    [No Abstract]   [Full Text] [Related]  

  • 93. India takes an open source approach to drug discovery.
    Singh S
    Cell; 2008 Apr; 133(2):201-3. PubMed ID: 18423188
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Pharmacogenomics: principles and perspectives].
    Mahlknecht U
    Dtsch Med Wochenschr; 2006 Feb; 131(7):310-3. PubMed ID: 16468099
    [No Abstract]   [Full Text] [Related]  

  • 95. Biopharmaceuticals: new technology unlocks the body's medicine cabinet.
    Zoler ML
    Med World News; 1985 Mar; 26(6):40-2, 45, 49-51 passim. PubMed ID: 10270395
    [No Abstract]   [Full Text] [Related]  

  • 96. [Innovation and therapeutic progress].
    Revuz J
    Ann Dermatol Venereol; 2006 Feb; 133(2):111-2. PubMed ID: 16508592
    [No Abstract]   [Full Text] [Related]  

  • 97. Current status and future direction of the molecular modeling industry.
    Richon AB
    Drug Discov Today; 2008 Aug; 13(15-16):665-9. PubMed ID: 18675761
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Editorial: biopharmaceutical technologies.
    Jungbauer A
    Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
    [No Abstract]   [Full Text] [Related]  

  • 99. New Zealand: unique biodiversity and world-class science converge.
    Boalch C
    Drug Discov Today; 2006 Aug; 11(15-16):677-80. PubMed ID: 16846794
    [No Abstract]   [Full Text] [Related]  

  • 100. Evolving ways that drug therapy is individualized.
    Reidenberg MM
    Clin Pharmacol Ther; 2003 Sep; 74(3):197-202. PubMed ID: 12966363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.